Osaka Study for COVID-19 vaccine at Geriatric facilities

JRCT ID: jRCT1051200148

Registered date:05/03/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: none
• Date of first enrollment: 08/03/2021
• Target sample size: 300
• Study type: Observational

Outcome(s)

• Primary Outcome: immunogenicity
• Secondary Outcome: effectiveness, side effects after vaccination, vaccine associatd adverse events, immunogenicity based on the neutralizing antibody

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. Residents and staffs at Osaka geriatric intermediate care facilities who wish to receive COVID-19 vaccine
2. Those who can follow the study schedule during the follow-up period
3. Written informed consent

Exclude criteria

1. Those who have a condition under the contraindications for vaccination
2. Those who are judged to be inappropriate as study subjects by the investigator

Related Information

• Primary Sponsor: Nakata Hiroyuki
• Secondary Sponsor: Hirota Yoshio,Ohfuji Satoko